首页 > 最新文献

Revista de la Facultad de Ciencias Medicas de Cordoba最新文献

英文 中文
Cardiomiopatía cirrótica – ¿Realidad clínica o simple curiosidad académica? Revisión. 肝硬化心肌病--临床现实还是学术好奇?回顾。
Q3 Medicine Pub Date : 2024-03-27 DOI: 10.31053/1853.0605.v81.n1.44419
Hugo Ramos, Mario Altieri

El diagnóstico de Cardiomiopatía Cirrótica está basado en la presencia de cirrosis hepática avanzada con alteraciones de la función cardíaca sin cardiopatía pre-existente, pero en gran parte de su evolución natural ésta es subclínica. Por ello son imprescindibles los estudios complementarios no invasivos para confirmar el diagnóstico y su rol pronóstico en pacientes con o sin trasplante hepático. En esta segunda parte revisamos los métodos de diagnóstico desde el ECG hasta las imágenes de resonancia magnética cardíaca.

肝硬化性心肌病的诊断依据是晚期肝硬化伴有心脏功能的改变,且无先本性心脏病。因此,非侵入性辅助研究对于确诊及其在接受或未接受肝移植的患者中的预后作用至关重要。在第二部分中,我们将回顾从心电图到心脏磁共振成像的诊断方法。
{"title":"Cardiomiopatía cirrótica – ¿Realidad clínica o simple curiosidad académica? Revisión.","authors":"Hugo Ramos, Mario Altieri","doi":"10.31053/1853.0605.v81.n1.44419","DOIUrl":"10.31053/1853.0605.v81.n1.44419","url":null,"abstract":"<p><p>El diagnóstico de Cardiomiopatía Cirrótica está basado en la presencia de cirrosis hepática avanzada con alteraciones de la función cardíaca sin cardiopatía pre-existente, pero en gran parte de su evolución natural ésta es subclínica. Por ello son imprescindibles los estudios complementarios no invasivos para confirmar el diagnóstico y su rol pronóstico en pacientes con o sin trasplante hepático. En esta segunda parte revisamos los métodos de diagnóstico desde el ECG hasta las imágenes de resonancia magnética cardíaca.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"81 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Implementation of teleconsultation in hospitals in the city of Cordoba during the SARS-CoV-2 pandemic] 在 SARS-CoV-2 大流行期间,在科尔多瓦首都医院实施远程会诊。
Q3 Medicine Pub Date : 2024-03-27 DOI: 10.31053/1853.0605.v81.n1.42231
María Virginia Boaglio, Gianmarco Llarena Billia, Ingrid Strusberg

Teleconsultation is one of the assets of telemedicine that allows medical professionals to provide diagnostic or therapeutic advice to patients through electronic means. The objective of this study was to estimate the frequency of teleconsultation implementation in hospitals in the city of Cordoba from 2020 to 2022. A descriptive, observational and cross-sectional study was carried out, providing an online survey (Google Forms) to hospital representatives in Córdoba. Descriptive statistics were used. The study was conducted in 30 out of the 50 hospitals in the city, including 17 private (57%) and 13 public institutions (43%). Teleconsultation was provided by a higher percentage of private healthcare facilities (82%) compared to public ones (77%). The results showed that the SARS-CoV-2 pandemic was the main driver behind the implementation of teleconsultation, with 92% of all hospitals having implemented it due to the pandemic while the remaining 8% had already offered this service prior to the pandemic. The most requested services were Internal Medicine and Infectology, and phone calls were the most commonly used tool. Among the hospitals that did not offer teleconsultation, 67% did not plan to do so in the future, while the remaining 33% were making arrangements for its implementation in 2023. Although the pandemic catalyzed the implementation of teleconsultations in most hospitals, there are still some institutions that do not plan to incorporate this modality. This study provides valuable data for improving future medical care strategies in the city of Cordoba.

远程会诊是远程医疗的优势之一,被定义为一系列医患互动,其目的是通过电子手段提供诊断或治疗建议。本研究的主要目的是估算 2020-2022 年期间科尔多瓦市各医院实施远程会诊的频率。本研究是一项描述性、观察性和横断面研究,向科尔多瓦市各医院的管理人员提供了一份在线调查表(谷歌表格)。调查采用了描述性统计方法。该市 50 家医院的 30 名代表接受了采访,其中 17 家为私立医院(57%),13 家为公立医院(43%)。在私立医院中,82%的医院提供远程会诊,而公立医院的这一比例为 77%。其中,92% 的医院是因为 SARS-CoV-2 大流行才开始提供远程会诊服务的,另外 8%的医院是以前就提供过远程会诊服务的。需求量最大的服务是医疗诊所和传染病。电话是最常用的工具。在没有提供远程会诊的医院中,67%的医院不打算在未来提供远程会诊,其余的医院正在安排在 2023 年实施远程会诊。SARS-CoV-2 大流行促进了大多数受访医院实施远程会诊。尽管会诊的可及性不断提高,但仍有一些医院不打算采用这种方式。这些数据可为改进科尔多瓦市未来的医疗保健战略提供依据。
{"title":"[Implementation of teleconsultation in hospitals in the city of Cordoba during the SARS-CoV-2 pandemic]","authors":"María Virginia Boaglio, Gianmarco Llarena Billia, Ingrid Strusberg","doi":"10.31053/1853.0605.v81.n1.42231","DOIUrl":"10.31053/1853.0605.v81.n1.42231","url":null,"abstract":"<p><p>Teleconsultation is one of the assets of telemedicine that allows medical professionals to provide diagnostic or therapeutic advice to patients through electronic means. The objective of this study was to estimate the frequency of teleconsultation implementation in hospitals in the city of Cordoba from 2020 to 2022. A descriptive, observational and cross-sectional study was carried out, providing an online survey (Google Forms) to hospital representatives in Córdoba. Descriptive statistics were used. The study was conducted in 30 out of the 50 hospitals in the city, including 17 private (57%) and 13 public institutions (43%). Teleconsultation was provided by a higher percentage of private healthcare facilities (82%) compared to public ones (77%). The results showed that the SARS-CoV-2 pandemic was the main driver behind the implementation of teleconsultation, with 92% of all hospitals having implemented it due to the pandemic while the remaining 8% had already offered this service prior to the pandemic. The most requested services were Internal Medicine and Infectology, and phone calls were the most commonly used tool. Among the hospitals that did not offer teleconsultation, 67% did not plan to do so in the future, while the remaining 33% were making arrangements for its implementation in 2023. Although the pandemic catalyzed the implementation of teleconsultations in most hospitals, there are still some institutions that do not plan to incorporate this modality. This study provides valuable data for improving future medical care strategies in the city of Cordoba.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"81 1","pages":"128-142"},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110666/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Compliance with a WHO guideline for cardiovascular disease prevention. A population based cross-sectional study in Argentina. 世界卫生组织心血管疾病预防指南的遵守情况。阿根廷人口横断面研究。
Q3 Medicine Pub Date : 2024-03-27 DOI: 10.31053/1853.0605.v81.n1.41876
Pablo Gulayin, Laura Gutierrez, Fernando Lanas, Nora Mores, Jacqueline Ponzo, Matías Calandrelli, Rosana Poggio, Vilma Irazola

Introduction: Current recommendations for cardiovascular disease (CVD) prevention are guided CVD risk classification. This study aims to analyze the level of compliance with pharmacological and non-pharmacological recommendations outlined in the World Health Organization (WHO) CVD prevention clinical practice guideline within the general population of two cities in Argentina.

Methods: We analyzed the compliance with preventive recommendations from the WHO 2007 Guidelines for Management of Cardiovascular Risk in two cities of Argentina participating in the CESCAS population-based study in the Southern Cone of Latin America.

Results: 3990 participants were included. Considering the WHO recommendations, the use of antiplatelet medication was 5.6% (95% CI 3.5, 8.9) in primary prevention and 20.5% (95%= CI 16.0, 25.9) in secondary prevention. Regarding lipid-lowering medication, it was 6.7% (CI 95%= 4.4, 10.1) and 15.4% (CI 95%= 11.6, 20.1), respectively. As per non-pharmacological recommendations in the general population: low intake of fruit and vegetables was 78.4% (CI 95%= 76.8, 79.9); low physical activity was 26.9% (CI 95%= 25.3, 28.5), current cigarette smoking was 28.3% (CI 95%= 26.6, 30.0), overweight/obesity was 73.9% (CI 95%= 72.3, 75.6), and excessive alcohol intake was 2.6% (CI 95%= 2.1, 3.4).

Conclusions: It was observed a significantly low compliance with pharmacological and non-pharmacological recommendations for CVD prevention in the general population of two cities in Argentina. Urgent efforts are needed to improve compliance to cardiovascular preventive recommendations promoted by CPG, especially in Low- and Middle- Income Countries.

导言:目前的心血管疾病(CVD)预防建议以心血管疾病风险分类为指导。本研究旨在分析阿根廷两个城市的普通人群对世界卫生组织(WHO)心血管疾病预防临床实践指南中提出的药物和非药物建议的遵从程度:我们分析了参与拉丁美洲南锥体地区 CESCAS 人口研究的阿根廷两座城市对《2007 年世界卫生组织心血管风险管理指南》中预防建议的遵从情况:结果:共纳入 3990 名参与者。根据世卫组织的建议,一级预防中抗血小板药物的使用率为 5.6% (95% CI 3.5, 8.9),二级预防中为 20.5% (95%= CI 16.0, 25.9)。降血脂药物的使用率分别为 6.7% (CI 95%= 4.4, 10.1) 和 15.4% (CI 95%= 11.6, 20.1)。一般人群中的非药物建议:水果和蔬菜摄入量低的占 78.4% (CI 95%= 76.8,79.9);体力活动少的占 26.9% (CI 95%= 25.3,28.5);目前吸烟的占 28.3% (CI 95%= 26.6,30.0);超重/肥胖的占 73.9% (CI 95%= 72.3,75.6);过量饮酒的占 2.6% (CI 95%= 2.1,3.4):据观察,阿根廷两个城市的普通人群对预防心血管疾病的药物和非药物建议的依从性很低。亟需做出努力,提高对 CPG 倡导的心血管预防建议的依从性,尤其是在中低收入国家。
{"title":"Compliance with a WHO guideline for cardiovascular disease prevention. A population based cross-sectional study in Argentina.","authors":"Pablo Gulayin, Laura Gutierrez, Fernando Lanas, Nora Mores, Jacqueline Ponzo, Matías Calandrelli, Rosana Poggio, Vilma Irazola","doi":"10.31053/1853.0605.v81.n1.41876","DOIUrl":"10.31053/1853.0605.v81.n1.41876","url":null,"abstract":"<p><strong>Introduction: </strong>Current recommendations for cardiovascular disease (CVD) prevention are guided CVD risk classification. This study aims to analyze the level of compliance with pharmacological and non-pharmacological recommendations outlined in the World Health Organization (WHO) CVD prevention clinical practice guideline within the general population of two cities in Argentina.</p><p><strong>Methods: </strong>We analyzed the compliance with preventive recommendations from the WHO 2007 Guidelines for Management of Cardiovascular Risk in two cities of Argentina participating in the CESCAS population-based study in the Southern Cone of Latin America.</p><p><strong>Results: </strong>3990 participants were included. Considering the WHO recommendations, the use of antiplatelet medication was 5.6% (95% CI 3.5, 8.9) in primary prevention and 20.5% (95%= CI 16.0, 25.9) in secondary prevention. Regarding lipid-lowering medication, it was 6.7% (CI 95%= 4.4, 10.1) and 15.4% (CI 95%= 11.6, 20.1), respectively. As per non-pharmacological recommendations in the general population: low intake of fruit and vegetables was 78.4% (CI 95%= 76.8, 79.9); low physical activity was 26.9% (CI 95%= 25.3, 28.5), current cigarette smoking was 28.3% (CI 95%= 26.6, 30.0), overweight/obesity was 73.9% (CI 95%= 72.3, 75.6), and excessive alcohol intake was 2.6% (CI 95%= 2.1, 3.4).</p><p><strong>Conclusions: </strong>It was observed a significantly low compliance with pharmacological and non-pharmacological recommendations for CVD prevention in the general population of two cities in Argentina. Urgent efforts are needed to improve compliance to cardiovascular preventive recommendations promoted by CPG, especially in Low- and Middle- Income Countries.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"81 1","pages":"96-114"},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110661/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical reasoning and artificial intelligence. [临床推理与人工智能。
Q3 Medicine Pub Date : 2023-12-26 DOI: 10.31053/1853.0605.v80.n4.42544
Eduardo Cuestas

.

.
{"title":"[Clinical reasoning and artificial intelligence.","authors":"Eduardo Cuestas","doi":"10.31053/1853.0605.v80.n4.42544","DOIUrl":"10.31053/1853.0605.v80.n4.42544","url":null,"abstract":"<p><p>.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"80 4","pages":"306-310"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851391/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Recommendations for psoriasis treatment in Pediatrics]. [儿科银屑病治疗建议]。
Q3 Medicine Pub Date : 2023-12-26 DOI: 10.31053/1853.0605.v80.n4.42874
Paula Carolina Luna, María Eugenia Abad, Margarita Larralde, Paula Boggio, Bruno Ferrari, María Fernanda Maccario, Carla Castro, Silvia Moreno, Débora Kaplan, Cristina Echeverría

Introduction: in one third of patients with psoriasis, symptoms start during childhood and adolescence, with a strong emotional and psychosocial impact.

Objective: to develop a guideline for the systemic treatment of psoriasis in pediatric patients by means of recommendations based on the best available evidence.

Materials and methods: Sources: articles indexed in PubMed, Epistemonikos, Google Scholar, Cochrane Library and Scielo, published between January 2010 and May 2022, in English, Spanish and Portuguese. Study selection: evidence-based clinical practice guidelines, systematic reviews, meta-analyses, randomized controlled studies, observational studies (case-control, cohort studies, real-life registries) and evaluations of biosimilar drugs in patients up to and including 17 years of age were considered. The keywords "psoriasis" and "treatment" were used in all three languages. Data extraction: the literature was evaluated using Grading of Recommendations Assessment, Development and Evaluation (GRADE) recommendations. Data synthesis: evidence tables were developed and analyzed by the expert committee. The questions for the development of recommendations were based on the PICO system (population, intervention, comparison, outcome).

Results: A total of 8 recommendations and 7 points of good practice were developed. The direction and strength of the recommendations were expressed according to the GRADE system.

Conclusions: the final decision on a specific therapy should be based on the best opinion of the treating physician, the individual characteristics, and the values and preferences of the patients and their caregivers.

引言:三分之一的银屑病患者在儿童和青少年时期开始出现症状,对情绪和社会心理有很大影响。目的:根据现有最佳证据提出建议,为儿童银屑病患者的系统治疗制定指南:资料来源:PubMed、Epistemonikos、Google Scholar、Cochrane Library 和 Scielo 中收录的 2010 年 1 月至 2022 年 5 月间发表的文章,语言包括英语、西班牙语和葡萄牙语。研究选择:以证据为基础的临床实践指南、系统综述、荟萃分析、随机对照研究、观察性研究(病例对照、队列研究、真实生活登记)以及对 17 岁以下(含 17 岁)患者使用生物类似药的评估均在考虑之列。所有三种语言均使用关键词 "银屑病 "和 "治疗"。数据提取:采用建议评估、发展和评价分级(GRADE)建议对文献进行评估。数据综合:专家委员会制定并分析了证据表。根据 PICO 系统(人群、干预、比较、结果)提出建议问题:结果:共制定了 8 项建议和 7 点良好做法。结论:关于具体疗法的最终决定应基于主治医生的最佳意见、个体特征以及患者及其护理人员的价值观和偏好。
{"title":"[Recommendations for psoriasis treatment in Pediatrics].","authors":"Paula Carolina Luna, María Eugenia Abad, Margarita Larralde, Paula Boggio, Bruno Ferrari, María Fernanda Maccario, Carla Castro, Silvia Moreno, Débora Kaplan, Cristina Echeverría","doi":"10.31053/1853.0605.v80.n4.42874","DOIUrl":"10.31053/1853.0605.v80.n4.42874","url":null,"abstract":"<p><strong>Introduction: </strong>in one third of patients with psoriasis, symptoms start during childhood and adolescence, with a strong emotional and psychosocial impact.</p><p><strong>Objective: </strong>to develop a guideline for the systemic treatment of psoriasis in pediatric patients by means of recommendations based on the best available evidence.</p><p><strong>Materials and methods: </strong>Sources: articles indexed in PubMed, Epistemonikos, Google Scholar, Cochrane Library and Scielo, published between January 2010 and May 2022, in English, Spanish and Portuguese. Study selection: evidence-based clinical practice guidelines, systematic reviews, meta-analyses, randomized controlled studies, observational studies (case-control, cohort studies, real-life registries) and evaluations of biosimilar drugs in patients up to and including 17 years of age were considered. The keywords \"psoriasis\" and \"treatment\" were used in all three languages. Data extraction: the literature was evaluated using Grading of Recommendations Assessment, Development and Evaluation (GRADE) recommendations. Data synthesis: evidence tables were developed and analyzed by the expert committee. The questions for the development of recommendations were based on the PICO system (population, intervention, comparison, outcome).</p><p><strong>Results: </strong>A total of 8 recommendations and 7 points of good practice were developed. The direction and strength of the recommendations were expressed according to the GRADE system.</p><p><strong>Conclusions: </strong>the final decision on a specific therapy should be based on the best opinion of the treating physician, the individual characteristics, and the values and preferences of the patients and their caregivers.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"80 4","pages":"523-537"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851392/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Real-world evidence on pharmacological appropriateness in type 2 diabetes mellitus and cardiovascular disease]. 2 型糖尿病和心血管疾病药理适宜性的现实证据。
Q3 Medicine Pub Date : 2023-12-26 DOI: 10.31053/1853.0605.v80.n4.42272
Carolina Pintos, Mariana Andrea Burgos, Natalia Inés Pasik, Sofía Piccioli, María Florencia Grande Ratti, María Paula Russo

Objective: To estimate the proportion of individuals with established Type 2 Diabetes Mellitus (T2DM) and Cardiovascular Disease (CVD) who are receiving pharmacological anti-diabetic treatment with evidence of cardiovascular benefit at a hospital in Argentina.

Materials and methods: Cross-sectional study conducted at the Italian Hospital of Buenos Aires. A consecutive sample of adult patients affiliated with the institutional prepaid health plan active in March 2020, diagnosed with T2DM and established CVD, was included. Data were collected from the Electronic Health Record. The proportion of pharmacological adequacy (combined use of metformin plus sodium-glucose co-transporter 2 inhibitors and/or glucagon-like peptide 1 receptor agonists) was reported along with its respective 95% confidence interval (CI).

Results: A total of 1539 patients were included, with a mean age of 76.2 years; 65.3% were male, and 81.6% were overweight or obese. Hemoglobin A1c levels were recorded in the past year for 74.9% of patients, with an average value of 6.9% (SD 1.2). The most prescribed drugs were metformin (61.3%), insulin (26.7%), and gliptins (11%). Out of the total included patients, 82 exhibited pharmacotherapeutic adequacy for diabetes treatment, with a prevalence of 5.3% (95% CI 4.2-6.5).

Conclusions: The prevalence of prescribing anti-diabetic drugs with evidence of cardiovascular benefit was 5.3% (95% CI 4.2-6.5). This real-world evidence highlights the low frequency of prescribing this type of medication at the time of the study in a high cardiovascular risk population.

目的:估计阿根廷一家医院中接受有心血管获益证据的抗糖尿病药物治疗的 2 型糖尿病(DM2)和已确诊心血管疾病(CVD)患者的比例。材料与方法:在布宜诺斯艾利斯意大利医院进行的横断面研究。研究连续抽样调查了截至 2020 年 3 月一家预付医疗保险公司的成年患者,这些患者被诊断为 DM2 并已确诊为心血管疾病。数据来自电子病历。报告了药物治疗的适当性比例(二甲双胍加钠葡萄糖共转运体 2 型抑制剂和/或胰高血糖素样肽 1 型激动剂的联合使用)及其各自的 95%CI 值。 结果共纳入 1539 名患者,平均年龄 76.2 岁,65.3% 为男性,81.6% 为超重或肥胖。74.9% 的患者在过去一年中记录了糖化血红蛋白,平均值为 6.9%(SD 1.2)。处方最多的药物是:二甲双胍(61.3%)、胰岛素(26.7%)和格列汀类(11%)。在纳入的所有患者中,82 人接受了适当的抗糖尿病药物治疗,患病率为 5.3%(95% CI 4.2-6.5):结论:有心血管获益证据的抗糖尿病药物处方比例为 5.3%(95%CI 4.2-6.5)。从现实世界的证据中得出的这一信息表明,在研究期间,心血管疾病高危人群处方此类药物的频率较低。
{"title":"[Real-world evidence on pharmacological appropriateness in type 2 diabetes mellitus and cardiovascular disease].","authors":"Carolina Pintos, Mariana Andrea Burgos, Natalia Inés Pasik, Sofía Piccioli, María Florencia Grande Ratti, María Paula Russo","doi":"10.31053/1853.0605.v80.n4.42272","DOIUrl":"10.31053/1853.0605.v80.n4.42272","url":null,"abstract":"<p><strong>Objective: </strong>To estimate the proportion of individuals with established Type 2 Diabetes Mellitus (T2DM) and Cardiovascular Disease (CVD) who are receiving pharmacological anti-diabetic treatment with evidence of cardiovascular benefit at a hospital in Argentina.</p><p><strong>Materials and methods: </strong>Cross-sectional study conducted at the Italian Hospital of Buenos Aires. A consecutive sample of adult patients affiliated with the institutional prepaid health plan active in March 2020, diagnosed with T2DM and established CVD, was included. Data were collected from the Electronic Health Record. The proportion of pharmacological adequacy (combined use of metformin plus sodium-glucose co-transporter 2 inhibitors and/or glucagon-like peptide 1 receptor agonists) was reported along with its respective 95% confidence interval (CI).</p><p><strong>Results: </strong>A total of 1539 patients were included, with a mean age of 76.2 years; 65.3% were male, and 81.6% were overweight or obese. Hemoglobin A1c levels were recorded in the past year for 74.9% of patients, with an average value of 6.9% (SD 1.2). The most prescribed drugs were metformin (61.3%), insulin (26.7%), and gliptins (11%). Out of the total included patients, 82 exhibited pharmacotherapeutic adequacy for diabetes treatment, with a prevalence of 5.3% (95% CI 4.2-6.5).</p><p><strong>Conclusions: </strong>The prevalence of prescribing anti-diabetic drugs with evidence of cardiovascular benefit was 5.3% (95% CI 4.2-6.5). This real-world evidence highlights the low frequency of prescribing this type of medication at the time of the study in a high cardiovascular risk population.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"80 4","pages":"335-351"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851389/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Acid-base balance and long COVID: comments on metabolic-respiratory alterations]. [酸碱平衡与长期 COVID:关于代谢-呼吸改变的评论]。
Q3 Medicine Pub Date : 2023-12-26 DOI: 10.31053/1853.0605.v80.n4.42580
Brian Johan Bustos-Viviescas, Rafael Enrique Lozano Zapata, Carlos Enrique García Yerena

Long COVID is a multi-organ pathology with important sequelae that affect the health and welfare of survivors from the cellular bioenergetics, in this case, the importance of considering the acid-base balance within the processes of evaluation and treatment of long COVID by health and sports professionals was addressed, given that different investigations have found important modifications in mitochondrial function that result in ventilation failures, causing alterations in the compensation-decompensation of respiratory and renal pH control (metabolic-respiratory acidosis and alkalosis).

长期慢性阻塞性肺气肿是一种多器官病变,具有重要的后遗症,会从细胞生物能方面影响幸存者的健康和福祉。在这种情况下,考虑到不同的研究发现线粒体功能发生了重要变化,导致通气功能衰竭,引起呼吸和肾脏酸碱度控制的补偿-解补偿改变(代谢-呼吸性酸中毒和碱中毒),卫生和体育专业人员在评估和治疗长期慢性阻塞性肺气肿的过程中考虑酸碱平衡问题就显得尤为重要。
{"title":"[Acid-base balance and long COVID: comments on metabolic-respiratory alterations].","authors":"Brian Johan Bustos-Viviescas, Rafael Enrique Lozano Zapata, Carlos Enrique García Yerena","doi":"10.31053/1853.0605.v80.n4.42580","DOIUrl":"10.31053/1853.0605.v80.n4.42580","url":null,"abstract":"<p><p>Long COVID is a multi-organ pathology with important sequelae that affect the health and welfare of survivors from the cellular bioenergetics, in this case, the importance of considering the acid-base balance within the processes of evaluation and treatment of long COVID by health and sports professionals was addressed, given that different investigations have found important modifications in mitochondrial function that result in ventilation failures, causing alterations in the compensation-decompensation of respiratory and renal pH control (metabolic-respiratory acidosis and alkalosis).</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"80 4","pages":"568-573"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Historic evocation] [历史唤醒]
Q3 Medicine Pub Date : 2023-12-26 DOI: 10.31053/1853.0605.v80.n4.43234
Norma Acerbi Cremades
{"title":"[Historic evocation]","authors":"Norma Acerbi Cremades","doi":"10.31053/1853.0605.v80.n4.43234","DOIUrl":"10.31053/1853.0605.v80.n4.43234","url":null,"abstract":"","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"80 4","pages":"311-313"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851405/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ultrasound guided biopsy of lung tumors: evaluation of efficacy and complications]. 超声引导下的肺部肿瘤活检。
Q3 Medicine Pub Date : 2023-12-26 DOI: 10.31053/1853.0605.v80.n4.40922
Juan Bautista Del Valle, Marina Alonso Serena, Gabriel Ducrey, Jésica Lorena Savluk, Matías Adrián Borensztein

Introduction: The diagnosis of lung cancer, as well as that of lung nodules, is increasing. Percutaneous biopsy has become a transcendental tool for its diagnosis. Traditionally, computed tomography is used for these procedures because of its ability to clearly demonstrate bone and aerated lung. However, in selected cases it can be performed with ultrasound.

Methods: Retrospective study conducted between January 2020 and December 2021, during the SARS-CoV-2 pandemic. All patients had pleural-based lung lesions or pleural lesions, some with a known history of cancer.

Results: Thirty-six procedures were performed, in 32 (88.9%) the sample obtained presented diagnostic yield and the most used additional test was Immunohistochemistry in 23 (63.9%). Complications were reported in 5 patients (13.9%): 2 with mild pneumothorax, 2 with hemothorax (1 mild and 1 moderate) and 1 patient reported pain.

Conclusion: Ultrasound is a valid method to be used as a guide for biopsies of pleural and peripheral pulmonary lesions. The complications and diagnostic rate has been shown to be in line with the experience of other authors and international guidelines.

导言肺癌和肺结节的诊断率不断上升。经皮活检已成为一种重要的诊断工具。传统上,由于计算机断层扫描能清晰显示骨骼和通气的肺部,因此被用于这些手术。不过,在特定病例中,也可使用超声波进行检查。方法:在 2020 年 1 月至 2021 年 12 月 SARS-CoV-2 大流行期间进行的回顾性研究。所有患者均有以胸膜为基础的肺部病变或胸膜病变,其中一些患者已知有癌症病史。结果:共进行了 36 例手术,其中 32 例(88.9%)获得的标本具有诊断价值,23 例(63.9%)最常用的附加检查是免疫组化。有 5 名患者(13.9%)报告了并发症:2 人轻度气胸,2 人血胸(1 人轻度,1 人中度),1 名患者报告疼痛。结论:超声波检查是引导胸膜和周围肺部病变活检的有效方法。并发症和再诊断率与其他学者的经验和国际指南一致。
{"title":"[Ultrasound guided biopsy of lung tumors: evaluation of efficacy and complications].","authors":"Juan Bautista Del Valle, Marina Alonso Serena, Gabriel Ducrey, Jésica Lorena Savluk, Matías Adrián Borensztein","doi":"10.31053/1853.0605.v80.n4.40922","DOIUrl":"10.31053/1853.0605.v80.n4.40922","url":null,"abstract":"<p><strong>Introduction: </strong>The diagnosis of lung cancer, as well as that of lung nodules, is increasing. Percutaneous biopsy has become a transcendental tool for its diagnosis. Traditionally, computed tomography is used for these procedures because of its ability to clearly demonstrate bone and aerated lung. However, in selected cases it can be performed with ultrasound.</p><p><strong>Methods: </strong>Retrospective study conducted between January 2020 and December 2021, during the SARS-CoV-2 pandemic. All patients had pleural-based lung lesions or pleural lesions, some with a known history of cancer.</p><p><strong>Results: </strong>Thirty-six procedures were performed, in 32 (88.9%) the sample obtained presented diagnostic yield and the most used additional test was Immunohistochemistry in 23 (63.9%). Complications were reported in 5 patients (13.9%): 2 with mild pneumothorax, 2 with hemothorax (1 mild and 1 moderate) and 1 patient reported pain.</p><p><strong>Conclusion: </strong>Ultrasound is a valid method to be used as a guide for biopsies of pleural and peripheral pulmonary lesions. The complications and diagnostic rate has been shown to be in line with the experience of other authors and international guidelines.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"80 4","pages":"439-455"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851407/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[High-risk endometrial carcinoma in early stages: Hospital Italiano de Buenos Aires, oncological results]. 高风险早期子宫内膜癌。
Q3 Medicine Pub Date : 2023-12-26 DOI: 10.31053/1853.0605.v80.n4.40821
Diego Odetto, Maria Celeste Puga, Guido Martin Rey Valzacchi, Jose Martin Saadi, Liliana Beatriz Zamora, Maria Cecilia Riggi, Myriam Beatriz Perrotta

Introduction: Endometrial cancer is the second most frequent gynecological tumor in Argentina, representing 6% of all cancers in women. The objective of this study is to evaluate the oncological and perioperative results in patients with high-risk endometrial cancer (HREC) limited to the uterus, treated at the Hospital Italiano de Buenos Aires, between January 2010-2018.

Methods: Retrospective cohort study that evaluated perioperative results, disease-free survival at 2, 4 years in patients with HREC.

Results: Of a total of 123 patients, 74 met the inclusion criteria. Serous tumors were the most frequent histological type, n=38 (51%), while dedifferentiated tumors were the least frequent, n=2 (3%). Of all the patients included, 56 (76%) received at least one adjuvant treatment. Taxol platinum-based chemotherapy was implemented in 28 patients (38%), while 24 (33%) received a combination of chemotherapy and radiotherapy. The median follow-up time was 2.9 years. Disease-free survival in patients with stage IA at 2 and 4 years was 71% (95% CI 55-82) and 63% (CI 46-76), respectively, while those with stage IB were 53 (95% CI 33-70) and 38 (95% CI 19-58). Regarding the surgical approach, no significant differences were found in disease-free or overall survival when comparing the laparoscopic with the laparotomy approach (p=0.06).

Conclusion: Only the FIGO stage showed an increased probability of death or relapse regardless of the type of adjuvant treatment and the type of surgery approach. Perioperative complications were similar in both approaches.

简介在阿根廷,子宫内膜癌是第二大妇科肿瘤,占妇女癌症总数的 6%。本研究旨在评估2010年1月至2018年1月期间在布宜诺斯艾利斯意大利医院接受治疗的局限于子宫的高危子宫内膜癌(HREC)患者的肿瘤学和围手术期疗效。方法:回顾性队列研究,评估HUSC患者的围手术期疗效、2年和4年的无病生存率。 结果:74 名患者符合纳入标准。浆液性肿瘤发病率最高,为38例(51%),未分化肿瘤发病率最低,为2例(3%)。56名(76%)患者接受了至少一种辅助治疗。28名患者(38%)接受了全身治疗,24名患者(33%)接受了化疗和放疗联合治疗。 中位随访时间为 2.9 年。IA期患者2年和4年的无病生存率分别为71%(95% CI 55-82)和63%(CI 46-76),而IB期患者的无病生存率分别为53%(95% CI 33-70)和38%(95% CI 19-58)。在手术方式方面,无病生存率和围手术期并发症无明显差异。结论:无论采用哪种辅助治疗方法,只有FIGO分期显示死亡或复发的可能性增加。
{"title":"[High-risk endometrial carcinoma in early stages: Hospital Italiano de Buenos Aires, oncological results].","authors":"Diego Odetto, Maria Celeste Puga, Guido Martin Rey Valzacchi, Jose Martin Saadi, Liliana Beatriz Zamora, Maria Cecilia Riggi, Myriam Beatriz Perrotta","doi":"10.31053/1853.0605.v80.n4.40821","DOIUrl":"10.31053/1853.0605.v80.n4.40821","url":null,"abstract":"<p><strong>Introduction: </strong>Endometrial cancer is the second most frequent gynecological tumor in Argentina, representing 6% of all cancers in women. The objective of this study is to evaluate the oncological and perioperative results in patients with high-risk endometrial cancer (HREC) limited to the uterus, treated at the Hospital Italiano de Buenos Aires, between January 2010-2018.</p><p><strong>Methods: </strong>Retrospective cohort study that evaluated perioperative results, disease-free survival at 2, 4 years in patients with HREC.</p><p><strong>Results: </strong>Of a total of 123 patients, 74 met the inclusion criteria. Serous tumors were the most frequent histological type, n=38 (51%), while dedifferentiated tumors were the least frequent, n=2 (3%). Of all the patients included, 56 (76%) received at least one adjuvant treatment. Taxol platinum-based chemotherapy was implemented in 28 patients (38%), while 24 (33%) received a combination of chemotherapy and radiotherapy. The median follow-up time was 2.9 years. Disease-free survival in patients with stage IA at 2 and 4 years was 71% (95% CI 55-82) and 63% (CI 46-76), respectively, while those with stage IB were 53 (95% CI 33-70) and 38 (95% CI 19-58). Regarding the surgical approach, no significant differences were found in disease-free or overall survival when comparing the laparoscopic with the laparotomy approach (p=0.06).</p><p><strong>Conclusion: </strong>Only the FIGO stage showed an increased probability of death or relapse regardless of the type of adjuvant treatment and the type of surgery approach. Perioperative complications were similar in both approaches.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"80 4","pages":"352-366"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851395/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista de la Facultad de Ciencias Medicas de Cordoba
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1